Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estetrol/Drospirenone vs Reference COCs on Endocrine and Metabolic Parameters
NCT02957630Phase 2Completed
- Sponsor
- Estetra SRL
- Start
- Sep 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of estetrol in contraception (3 arms), sponsored by Estetra SRL. Primary endpoints: Plasma concentration of prothrombin fragment 1+2 at Cycle 6, Plasma concentration of APC resistance (ETP-based, APTT-based) at Cycle 6 and 45 more. Started Sep 2016; status: completed.
02
Drugs
estetrol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT02957630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02957630.